1nkemia IUCT Group SA represents a set of core values and a corporate philosophy centered on innovation, scientific excellence, and sustainability. The company prioritizes research and development to drive advancements in the chemical and biotech sectors. With a commitment to delivering cutting-edge solutions, 1nkemia IUCT Group SA fosters collaborations with industry partners, academia, and research centers. By harnessing its expertise and proprietary technologies, it aims to address global challenges and meet the evolving needs of its clients and society. The company's dedication to quality, integrity, and environmental responsibility further reinforces its position as a leading player in the field of chemistry and biotechnology.

1nkemia IUCT Group SA is primarily present in Spain and Europe.

Some significant milestones achieved by 1nkemia IUCT Group SA include expanding its product portfolio, increasing its global presence through partnerships and acquisitions, and receiving recognition and awards for its innovation and research efforts. The company has successfully developed and commercialized various chemical, pharmaceutical, and biotechnological products, contributing to its growth and market leadership. It has also established collaborations with renowned institutions and companies, enabling the exchange of knowledge and expertise. Furthermore, 1nkemia IUCT Group SA has been honored with several accolades, demonstrating its commitment to excellence in scientific research and development.

1nkemia IUCT Group SA is a renowned Spanish company with a rich history and background. Established in [year], the company specializes in [specify industry/sector]. Over the years, 1nkemia IUCT Group SA has become a leader in the field, offering a wide range of [products/services] to its clients. With a commitment to innovation and excellence, the company has successfully carved a niche for itself in the market. 1nkemia IUCT Group SA's dedication to quality, customer satisfaction, and technological advancements has helped it build a strong reputation within the industry. Today, it continues to grow and expand its presence both nationally and internationally, making it a prominent player in the global market.

The main competitors of 1nkemia IUCT Group SA in the market are companies like Company A, Company B, and Company C. These companies operate in a similar industry and offer products and services that can potentially compete with those of 1nkemia IUCT Group SA. However, 1nkemia IUCT Group SA differentiates itself through its unique portfolio and specialized expertise, setting it apart from its competitors in the market.

1nkemia IUCT Group SA is primarily active in the pharmaceutical and chemical industries.

The business model of 1nkemia IUCT Group SA focuses on providing innovative solutions and services in the fields of chemistry, pharmaceuticals, and biotechnology. As a leading company in the industry, 1nkemia IUCT Group SA specializes in research and development, process optimization, and technology transfer. With a strong emphasis on collaboration and strategic partnerships, the company leverages its expertise to develop and commercialize new products, processes, and technologies. By applying cutting-edge scientific knowledge and utilizing state-of-the-art facilities, 1nkemia IUCT Group SA aims to meet the evolving needs of its clients and make a significant impact in the global market.

De K/W-verhouding kan momenteel niet worden berekend voor 1nkemia IUCT Group.

De KUV kan momenteel niet worden berekend voor 1nkemia IUCT Group.

De AlleAktien Kwaliteitsscore voor 1nkemia IUCT Group is 1/10.

De omzet kan momenteel niet worden berekend voor 1nkemia IUCT Group.

De winst kan momenteel niet berekend worden voor 1nkemia IUCT Group.

The company 1nkemia IUCT Group SA specializes in the development, manufacturing, and marketing of products in various sectors of chemistry. The group has been active since 2004 and is headquartered in Spain. The business model of 1nkemia IUCT Group SA is based on the discovery and development of new technologies to produce innovative and high-quality products. The group specializes in three main segments: health, energy, and environment. In the health sector, 1nkemia IUCT Group SA offers various products and services tailored to the needs of the pharmaceutical industry. This includes the development of drugs, the manufacturing of active substances and catalysts, as well as research on biomaterials. The group is also specialized in the production of specific products for personalized medicine. In the energy sector, 1nkemia IUCT Group SA has developed innovative products that contribute to the use of renewable energies and the diversification of global energy supply. This includes products such as catalysts to improve the efficiency of fuel cells, as well as energy conversion and storage systems. In the environmental sector, 1nkemia IUCT Group SA has developed technologies to reduce environmental pollution and ensure quality assurance. This includes products such as catalysts for the removal of pollutants from air, water, and soil, as well as special bio-materials for accurate monitoring of environmental pollution. 1nkemia IUCT Group SA has a wide network of customers and partners around the world. The company works closely with universities, research institutions, and other industry players to develop the latest technologies and products. In addition to developing its own products, the group also offers a wide range of services focusing on the needs of its customers. This includes consulting services, research and development work, as well as technology transfer and licensing. In terms of product development, 1nkemia IUCT Group SA is committed to implementing sustainable practices and innovative technologies. The group emphasizes the use of clean technologies and the optimization of processes to minimize environmental impact. In summary, the business model of 1nkemia IUCT Group SA is based on the discovery and development of innovative technologies and products in various sectors of chemistry. The group specializes in developing products for the health, energy, and environment sectors and offers a wide range of services to its customers. 1nkemia IUCT Group SA is committed to sustainability by using clean technologies and optimizing processes to minimize environmental impact..

1nkemia IUCT Group keert een dividend van 0 EUR uit, verdeeld over betalingen per jaar.

De dividend kan momenteel niet worden berekend voor 1nkemia IUCT Group of het bedrijf keert geen dividend uit.

De ISIN van 1nkemia IUCT Group is ES0156303002.

Het WKN van 1nkemia IUCT Group is A1KBS4.

De ticker van 1nkemia IUCT Group is IKM.MC.

Binnen de laatste 12 maanden betaalde 1nkemia IUCT Group een dividend van . Dit komt overeen met een dividendrendement van ongeveer . Voor de komende 12 maanden zal 1nkemia IUCT Group naar verwachting een dividend van 0 EUR betalen.

De dividendrendement van 1nkemia IUCT Group is momenteel .

1nkemia IUCT Group betaalt elk kwartaal een dividend uit. Dit wordt uitgekeerd in de maanden .

1nkemia IUCT Group betaalde de afgelopen 0 jaar elk jaar dividend.

Voor de komende 12 maanden wordt een dividend van 0 EUR verwacht. Dit komt overeen met een dividendrendement van 0 %.

1nkemia IUCT Group wordt toegewezen aan de sector 'Gezondheid'.

Om het laatste dividend van 1nkemia IUCT Group van 22-12-2024 ter hoogte van 0 EUR te ontvangen, moest je het aandeel voor de ex-datum op 22-12-2024 in je portefeuille hebben.

De laatste dividenduitkering vond plaats op 22-12-2024.

In het jaar 2023 heeft 1nkemia IUCT Group 0 EUR aan dividenden uitgekeerd.

De dividenden van 1nkemia IUCT Group worden in EUR uitgekeerd.